Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.10
+0.06 (0.85%)
At close: Apr 28, 2026, 4:00 PM EDT
7.20
+0.10 (1.46%)
Pre-market: Apr 29, 2026, 8:24 AM EDT
Precision BioSciences Market Cap
Precision BioSciences has a market cap or net worth of $183.20 million as of April 29, 2026. Its market cap has increased by 297.23% in one year.
Market Cap
183.20M
Enterprise Value
96.43M
1-Year Change
297.23%
Ranking
Category
Stock Price
$7.10
Market Cap Chart
Since March 28, 2019, Precision BioSciences's market cap has decreased from $855.07M to $183.20M, a decrease of -78.57%. That is a compound annual growth rate of -19.53%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Canton Strategic Holdings | 193.20M |
| Sagimet Biosciences | 190.95M |
| Whitehawk Therapeutics | 190.20M |
| Korro Bio | 185.91M |
| Acumen Pharmaceuticals | 185.59M |
| Unicycive Therapeutics | 183.98M |
| Tonix Pharmaceuticals Holding | 179.13M |
| Cartesian Therapeutics | 178.94M |